CD82 and cancer: Another receptor tyrosine kinase that is suppressed by KAI1/CD82 is c-Met (also known as the hepatocyte growth factor receptor; HGFR), which is involved in oncogenic signaling in cancer cells (Figure 2) [68, 71].